IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Fairmount Funds Management LLC

Q2 2020 Holdings

Filed 2020-08-04 | 14 holdings | $57.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)COM004225108$28.4M585,51749.2%
Axsome Therapeutics Inc(AXSM)COM05464T104$17.8M216,09830.8%
Argenx SE(ARGX)SPONSORED ADR04016X101$11.4M50,45019.7%
Insmed Inc(INSM)COM PAR $.01457669307$27.8K1,010,7970.0%
Zogenix IncCOM NEW98978L204$26.3K971,8750.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$22.7K1,505,3950.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$16.6K603,8900.0%
Allakos Inc(ALLKGUSD)COM01671P100$12.8K178,6620.0%
Neoleukin Therapeutics IncCOM64049K104$12.8K770,0730.0%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$12.4K652,3510.0%
Trillium Therapeutics IncCOM NEW89620X506$12.0K1,483,1810.0%
Amarin Corp PLCSPONS ADR NEW023111206$9.7K1,403,2370.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$8.5K169,9490.0%
Kiniksa Pharmaceuticals LTDCOM CL AG5269C101$5.1K200,1250.0%